News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GeneNews (GEN.TO) Announces Proposed Non-Brokered Private Placement and Implementation of Share Consolidation


12/10/2012 9:15:53 AM

TORONTO, Dec. 7, 2012 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company"), a molecular diagnostics company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it is proposing to complete a private placement (the "Private Placement") of up to 66,666,666 common shares from treasury at a price of $0.09 per share for total gross proceeds to the Company of up to $6,000,000. GeneNews will use the proceeds to accelerate commercialization of the ColonSentry® test in the United States, development and validation of pipeline products, and general working capital purposes.

Read at GlobeNewswire


comments powered by Disqus
GeneNews
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES